These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2185111)
1. Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Noda K; Umeda F; Ono H; Hisatomi A; Chijiiwa Y; Nawata H; Ibayashi H Diabetes; 1990 May; 39(5):608-12. PubMed ID: 2185111 [TBL] [Abstract][Full Text] [Related]
2. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits. Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114 [TBL] [Abstract][Full Text] [Related]
3. Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat. Calcutt NA; Mizisin AP; Yaksh TL J Neurol Sci; 1993 Nov; 119(2):154-61. PubMed ID: 8277329 [TBL] [Abstract][Full Text] [Related]
4. Effect of ropivacaine on peripheral neuropathy in streptozocin diabetes-induced rats through TRPV1-CGRP pathway. Zhang N; Wei H; Wu W; Lin P; Chen Y; Liu Z; Wang H; Bian Y; Yu K; Lin S; Cui Y; Luo R; Lin J; Chen X Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31661547 [TBL] [Abstract][Full Text] [Related]
5. Substance P and somatostatin content and transport in vagus and sciatic nerves of the streptozocin-induced diabetic rat. MacLean DB Diabetes; 1987 Mar; 36(3):390-5. PubMed ID: 2433176 [TBL] [Abstract][Full Text] [Related]
6. Water content, vasoactive intestinal polypeptide and substance P in intact and crushed sciatic nerves of normal and streptozotocin-diabetic rats. Anand P; Llewelyn JG; Thomas PK; Gillon KR; Lisk R; Bloom SR J Neurol Sci; 1988 Feb; 83(2-3):167-77. PubMed ID: 2451710 [TBL] [Abstract][Full Text] [Related]
7. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes. Price DE; Airey CM; Alani SM; Wales JK Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a rat model of type II diabetic neuropathic pain. Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590 [TBL] [Abstract][Full Text] [Related]
9. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation. Szilvássy Z; Németh J; Kovács P; Paragh G; Sári R; Vígh L; Peitl B Metabolism; 2012 Jun; 61(6):776-86. PubMed ID: 22154324 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats. Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693 [TBL] [Abstract][Full Text] [Related]
13. Effects of Low-Intensity Treadmill Exercise on Sciatic Nerve in Experimental Diabetic Neuropathy. Gulsen I; Demiroglu M; Aycan A; Ucler R; Alaca I; Orhon ZN; Kanter M Anal Quant Cytopathol Histpathol; 2016 Apr; 38(2):95-102. PubMed ID: 27386630 [TBL] [Abstract][Full Text] [Related]
14. Sex differences in the manifestation of peripheral diabetic neuropathy in gonadectomized rats: a correlation with the levels of neuroactive steroids in the sciatic nerve. Pesaresi M; Giatti S; Cavaletti G; Abbiati F; Calabrese D; Bianchi R; Caruso D; Garcia-Segura LM; Melcangi RC Exp Neurol; 2011 Apr; 228(2):215-21. PubMed ID: 21241692 [TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus is associated with a decrease in vasoactive intestinal polypeptide content of gastrointestinal tract of rat. Adeghate E; Ponery AS; Sharma AK; El-Sharkawy T; Donáth T Arch Physiol Biochem; 2001 Jul; 109(3):246-51. PubMed ID: 11880929 [TBL] [Abstract][Full Text] [Related]
16. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Hellweg R; Raivich G; Hartung HD; Hock C; Kreutzberg GW Exp Neurol; 1994 Nov; 130(1):24-30. PubMed ID: 7821393 [TBL] [Abstract][Full Text] [Related]
17. Role of A3 adenosine receptor in diabetic neuropathy. Yan H; Zhang E; Feng C; Zhao X J Neurosci Res; 2016 Oct; 94(10):936-46. PubMed ID: 27319979 [TBL] [Abstract][Full Text] [Related]
18. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. Hellweg R; Hartung HD J Neurosci Res; 1990 Jun; 26(2):258-67. PubMed ID: 2142224 [TBL] [Abstract][Full Text] [Related]
19. Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals. Di Giulio AM; Gorio A; Bertelli A; Mantegazza P; Ferraris L; Ramacci MT Int J Clin Pharmacol Res; 1992; 12(5-6):243-6. PubMed ID: 1284499 [TBL] [Abstract][Full Text] [Related]
20. Reduction of cyclic AMP in the sciatic nerve of rats made diabetic with streptozotocin and the mechanism involved. Shindo H; Tawata M; Onaya T J Endocrinol; 1993 Mar; 136(3):431-8. PubMed ID: 7682591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]